← Leaderboards
Terry Bowlin
Microbiotix, Inc
$12,271,595
Attributed
$12,271,595
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.7M · FY2020–25$10M$7.5M$5M$2.5M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,271,595 · 2
By mechanism
N01$12,271,595 · 2
Top collaborators
No co-investigators on record.
Most similar at Microbiotix, Inc
Same institution · by research overlap
- Arnab Basu$15,329,434
- Gai Liu$3,152,933
- Norton P Peet$3,225,521
Others in their field
Other Emerging Leaders on “Advanced Development”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$378,174,673
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Joel A Lipkin · Four Points Technology, Llc$181,896,915
- Kimberly Smith · Ppd Development Lp$115,671,664
Research focus
Advanced DevelopmentPre-ClinicalChemistryTherapeutic CandidateResearch And DevelopmentProduct DevelopmentEfficacy EvaluationSafety AssessmentManufactureBacterial Antibiotic ResistanceEmerging Communicable DiseasesPathway InteractionsPseudomonas AeruginosaTherapeutic DevelopmentCategoriesNational Institute Of Allergy And Infectious DiseasePriority PathogenPathogenVirusCandidate SelectionAntiviral Drug DevelopmentLead OptimizationPandemic DiseaseClinical Assessments
Grant awards (7)
DEVELOPMENT OF PAN-FILOVIRUS THERAPEUTICS$2,938,788
N01 · FY2025 · AI · contact PI
Development of Therapeutic Products for Antibiotic Resistant Bacteria$2,742,219
N01 · FY2025 · AI · contact PI
Development of Therapeutic Products for Antibiotic Resistant Bacteria$2,485,753
N01 · FY2024 · AI · contact PI
DEVELOPMENT OF PAN-FILOVIRUS THERAPEUTICS$2,069,416
N01 · FY2023 · AI · contact PI
Development of Therapeutic Products for Antibiotic Resistant Bacteria$830,880
N01 · FY2023 · AI · contact PI
Development of Therapeutic Products for Antibiotic Resistant Bacteria$299,643
N01 · FY2022 · AI · contact PI
Development of Therapeutic Products for Antibiotic Resistant Bacteria$904,896
N01 · FY2020 · AI · contact PI